Skip to main content
. 2015 May 18;14:206. doi: 10.1186/s12936-015-0730-3

Table 2.

Cost-effectiveness of IPTp-SP

Intervention costs/ DALYs averted in US$ for 2012 Intervention
Results on clinical malaria [5] 46.02 IPTp-SP 2 doses vs Placebo
Results on neonatal mortality [5] 1.20 IPTp-SP 2 doses vs Placebo
Combined analysis for clinical malaria and neonatal mortality [5] 1.13 IPTp-SP 2 doses vs Placebo
Combined analysis for clinical malaria, maternal anaemia and low birth weight [8] 7.28 IPTp-SP 3+ doses vs IPTp-SP 2 doses